Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pileri

Showing results (151-160 of 524) with videos related to

Pageof 53
Sort By:
European Journal of Haematology|August 1, 1992
Multiple myeloma: intensified maintenance therapy with recombinant interferon-alpha-2b plus glucocorticoidsA Palumbo, M Boccadoro, L A Garino, et al.
Clinical and Experimental Immunology|January 1, 1990
Defective interleukin-2 induction of lymphokine-activated killer (LAK) activity in peripheral blood T lymphocytes of patients with monoclonal gammopathiesM Massaia, A Bianchi, U Dianzani, et al.
Blood|October 1, 1990
Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survivalP Omedé, M Boccadoro, G Gallone, et al.
Thrombosis and Haemostasis|October 6, 1997
Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTTB Montaruli, P Schinco, A Pannocchia, et al.
Annals of Hematology|January 27, 2000
Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemiaM Bazzan, G Tamponi, P Schinco, et al.
British Journal of Haematology|August 1, 1996
Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphomaP Corradini, M Ladetto, M Astolfi, et al.
Journal of Clinical & Laboratory Immunology|June 1, 1988
Emergence of activated lymphocytes in CD4 and CD8 subpopulations of multiple myeloma: correlation with the expansion of suppressor T-cells (CD8+ OKM1+) and ecto-5'nucleotidase deficiencyM Massaia, U Dianzani, P Pioppo, et al.
Histopathology|March 31, 2004
CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphomaV Franco, A M Florena, S Ascani, et al.
Blood|March 15, 1995
High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autograftingP Corradini, C Voena, M Astolfi, et al.
Best Practice & Research. Clinical Haematology|November 30, 2010
Immunohistochemical surrogates for genetic alterations of CCDN1, PML, ALK, and NPM1 genes in lymphomas and acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli, Enrico Tiacci, et al.
Pageof 53

Showing results (151-160 of 524) with videos related to

Sort By:
Pageof 53
European Journal of Haematology|August 1, 1992
Multiple myeloma: intensified maintenance therapy with recombinant interferon-alpha-2b plus glucocorticoidsA Palumbo, M Boccadoro, L A Garino, et al.
Clinical and Experimental Immunology|January 1, 1990
Defective interleukin-2 induction of lymphokine-activated killer (LAK) activity in peripheral blood T lymphocytes of patients with monoclonal gammopathiesM Massaia, A Bianchi, U Dianzani, et al.
Blood|October 1, 1990
Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survivalP Omedé, M Boccadoro, G Gallone, et al.
Thrombosis and Haemostasis|October 6, 1997
Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTTB Montaruli, P Schinco, A Pannocchia, et al.
Annals of Hematology|January 27, 2000
Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemiaM Bazzan, G Tamponi, P Schinco, et al.
British Journal of Haematology|August 1, 1996
Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphomaP Corradini, M Ladetto, M Astolfi, et al.
Journal of Clinical & Laboratory Immunology|June 1, 1988
Emergence of activated lymphocytes in CD4 and CD8 subpopulations of multiple myeloma: correlation with the expansion of suppressor T-cells (CD8+ OKM1+) and ecto-5'nucleotidase deficiencyM Massaia, U Dianzani, P Pioppo, et al.
Histopathology|March 31, 2004
CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphomaV Franco, A M Florena, S Ascani, et al.
Blood|March 15, 1995
High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autograftingP Corradini, C Voena, M Astolfi, et al.
Best Practice & Research. Clinical Haematology|November 30, 2010
Immunohistochemical surrogates for genetic alterations of CCDN1, PML, ALK, and NPM1 genes in lymphomas and acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli, Enrico Tiacci, et al.
Pageof 53